Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001607062-20-000307
Filing Date
2020-10-29
Accepted
2020-10-29 14:18:56
Documents
37
Period of Report
2020-07-31

Document Format Files

Seq Description Document Type Size
1 10-K ngio073120form10k.htm 10-K 432056
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 18461
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 18183
4 EXHIBIT 32 ex32.htm EX-32 6849
5 GRAPHIC image_001.jpg GRAPHIC 8216
  Complete submission text file 0001607062-20-000307.txt   1351563

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE ngio-20200731.xml EX-101.INS 110755
7 XBRL SCHEMA FILE ngio-20200731.xsd EX-101.SCH 16458
8 XBRL CALCULATION FILE ngio-20200731_cal.xml EX-101.CAL 17892
9 XBRL DEFINITION FILE ngio-20200731_def.xml EX-101.DEF 39224
10 XBRL LABEL FILE ngio-20200731_lab.xml EX-101.LAB 95291
11 XBRL PRESENTATION FILE ngio-20200731_pre.xml EX-101.PRE 82316
Mailing Address 10102 USA TODAY WAY MIRAMAR FL 33025
Business Address 10102 USA TODAY WAY MIRAMAR FL 33025 (416) 364-2551
NUGENEREX IMMUNO-ONCOLOGY, INC. (Filer) CIK: 0001804585 (see all company filings)

EIN.: 043208418 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 10-K | Act: 34 | File No.: 000-56153 | Film No.: 201271911
SIC: 2834 Pharmaceutical Preparations